Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 8,705 | 7,423 | 7,816 | 7,436 | 6,140 |
| Operating Income | -8,705 | -7,423 | -7,816 | -7,436 | -6,140 |
| Other Income | 1,515 | -3,044 | 4 | 1 | 0 |
| Pre-tax Income | -7,191 | -10,467 | -7,811 | -7,435 | -6,140 |
| Net Income Continuous | -7,191 | -10,407 | -7,811 | -7,435 | -6,140 |
| Net Income | $-7,191 | $-10,407 | $-7,811 | $-7,435 | $-6,140 |
| EPS Basic Total Ops | -19.22 | -30.33 | -38.44 | -36.64 | -30.03 |
| EPS Basic Continuous Ops | -19.17 | -30.21 | -38.39 | -36.54 | -30.18 |
| EPS Diluted Total Ops | -19.22 | -30.33 | -38.44 | -36.64 | -30.03 |
| EPS Diluted Continuous Ops | -19.17 | -30.21 | -38.39 | -36.54 | -30.18 |
| EBITDA(a) | $-8,663 | $-7,384 | $-7,783 | $-7,402 | $-6,097 |